Fungal Infections
Summary
- Guidelines from the WHO recommend treatment with amphotericin B and flucytosine (Management Guidelines)[WHO 2011]
Primary prophylaxis with fluconazole can be considered in settings where ART is not readily available or when amphotericin B or flucytosine is not available
- Widespread use of fluconazole has been associated with the emergence of fluconazole-resistant cryptococcal infection[Parkes-Ratanshi 2011; Bicanic 2006]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Cryptococcus